Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 15 to 23 amino acid residues in defined sequence
Reexamination Certificate
2006-08-29
2006-08-29
Turner, Sharon (Department: 1649)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
15 to 23 amino acid residues in defined sequence
C530S300000
Reexamination Certificate
active
07098304
ABSTRACT:
The invention concerns peptides which bind antibodies that are found in elevated levels in body fluids of schizophrenic patients and are found at a lower level or not found at all in body fluids of non-schizophrenic individuals. Using a computerized program, the antigenic epitope of the peptides of the invention is predicted as having a core of hydrophobic amino acids which is surrounded by positively charged amino acids. The peptides of the invention are useful in the diagnosis of schizophrenia in an individual.
REFERENCES:
patent: 6008001 (1999-12-01), Shinitzky
patent: 94/26107 (1994-11-01), None
patent: 95/23970 (1995-09-01), None
Russell et al., Biochem. J., 236:115-126, 1986.
Immunogenicity and Antigenic Specificity in Basic and Clinical Immunology, Ed. By Stites and Terr, Appleton Lange, Norwalk, Conn., 1991, pp. 101-108.
Skolnick et al., Trends in Biotech., 18(1):34-39, 2000.
Jobling et al, Mol. Microbiol., 1991, 5(7):1755-67.
Hedges etal., PNAS 91:2621-24, 1994 with alignment to SEQ ID No. 1.
Hedges et al., PNAS 91:2621-24, 1994 with alignment Accession ID I50026 database PIR—78.
Byrjalsen et al., WO98/10291, Mar. 12, 1998.
Taylor et al., Experimental and Molecular Pathology, (Apr. 1985) 42(2)271-7.
McAleese et al., Eur. J. Biochem., 178:413-17, 1988.
Jankovic B D, Journal of Immunology (Aug. 1985) 135 (2 Suppl) 853s-857s.
Blennow, K. et al., “Neuron specific enolase in cerebrospinal fluid: a biochemical marker for neuronal degeneration in demential disorders?” XP-002083586J Neural Transm(P-D Sect) (1994) 8:183-191.
Gabriel, S. et al., “Increased Concentrations of Presynaptic Proteins on the Cingulate Cortex of Subjects With Schizophrinia” XP-002116909Arch Gen Psychiatryvol. 54, (Jun. 1997) 559-566.
Ishiguro, A. et al “indentification ofCandida albincansAntigens Reactive with Immunoglobulin Antibody of Human Sera” XP-002116908Infection and Immunity(Apr. 1992) p. 1550-1557.
McAleese, Sybil M., et al., “Complete amino acid sequence of the neurone-specific γ isozyme of enolase (NSE) from human brain and comparison with the non-neuronal α form (NNE)”. Eur. J. Biochem, 178, 413-417 (1988).
Oliva, Daniele, et al., “Complete Structure of the Human Gene Encoding Neuron-Specific Enolase”. Genomics, 10, 157-165 (1991).
Egan, Michael F., et al., “Cereborspinal Fluid and Serum Levels of Neuron-Specific Enolase in Patients With Schizophrenia”. Psychiatry Research, 43, 187-195 (1992).
D2: Database EBI, accession No. P06733 (sequence update: Jan. 4, 1988).
Deckmann Michael
Shinitzky Meir
Hopkins Susanne M.
Nath Gary M.
Nath & Associates PLLC
Turner Sharon
Yeda Research and Development Co. Ltd.
LandOfFree
Assay for the diagnosis of schizophrenia based on a new peptide does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Assay for the diagnosis of schizophrenia based on a new peptide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Assay for the diagnosis of schizophrenia based on a new peptide will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3636634